| Deborah Kercheval, MD | |
|
322 N Main St, Kokomo, IN 46901-4622 | |
| (765) 453-8238 | |
| Not Available |
| Full Name | Deborah Kercheval |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 322 N Main St, Kokomo, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316045768 | NPI | - | NPPES |
| 20012850 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 01042031 (Indiana) | Primary |
| Entity Name | Southern Hills Counseling Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134118276 PECOS PAC ID: 5496642555 Enrollment ID: O20040303000105 |
News Archive
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, respiratory syncytial virus (RSV) and group A strep, with new traceability and secure patient health record documentation features and functionality.
Hip resurfacing – an alternative to hip replacement often recommended to younger patients – is prone to early failure in many instances, and should not be used in women, according to an Article published Online First in The Lancet.
The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies.
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.
› Verified 2 days ago
| Entity Name | Lifespring Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851489942 PECOS PAC ID: 5294624508 Enrollment ID: O20040315000128 |
News Archive
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, respiratory syncytial virus (RSV) and group A strep, with new traceability and secure patient health record documentation features and functionality.
Hip resurfacing – an alternative to hip replacement often recommended to younger patients – is prone to early failure in many instances, and should not be used in women, according to an Article published Online First in The Lancet.
The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies.
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Kercheval, MD 322 N Main St, Kokomo, IN 46901-4622 Ph: () - | Deborah Kercheval, MD 322 N Main St, Kokomo, IN 46901-4622 Ph: (765) 453-8238 |
News Archive
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, respiratory syncytial virus (RSV) and group A strep, with new traceability and secure patient health record documentation features and functionality.
Hip resurfacing – an alternative to hip replacement often recommended to younger patients – is prone to early failure in many instances, and should not be used in women, according to an Article published Online First in The Lancet.
The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies.
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.
› Verified 2 days ago
Dr. John Charles Stewart, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1907 W Sycamore St, Kokomo, IN 46901 Phone: 765-456-5900 Fax: 765-456-5815 | |
Mohan Prabu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2354 W Boulevard, Kokomo, IN 46902 Phone: 765-457-4800 | |
Dr. John Francis Schiltz, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 322 N Main St, Kokomo, IN 46901 Phone: 765-453-8555 | |
Anuradha Thumuluri, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 322 N Main St, Kokomo, IN 46901 Phone: 765-453-8555 | |
Donald Lee Roegner Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 702 West Alto Road, Kokomo, IN 46902 Phone: 765-453-7422 Fax: 765-453-3773 | |
Charles Evans, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3500 S Lafountain St, Kokomo, IN 46902 Phone: 765-776-3020 |